In previous studies, the prepared nanoparticles, which comprised a liposomal complex employing an anti-TfR single-chain variable fragment as a targeting ligand, carried the wtp53 gene, and showed anti-cancer activity by inducing death of both cancer stem cells and non-stem cancer cells [11]. This evidence concerns the gene TFRC and cancer.